Legal wrangling between the Trump Administration and House Republicans leaves $7 billion of Obamacare subsidies in question. That has health insurance executives reaching for antacid, because it means they may have to jack up premiums. They have to assume that fewer people will buy health insurance if they don’t get subsidies to pay for it, and that means price increases for everyone left on the individual market. 

Click the audio player above to hear the full story.